Clinical Trial Update: Grazoprevir (MK-5172) Administered With Peginterferon and Ribavirin in Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-003) [Phase 2]

View source ↗

Summary

This entry reports the completion of a Phase 2 trial (MK-5172-003) evaluating Grazoprevir in combination with Peginterferon and Ribavirin in treatment-naïve adu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Grazoprevir (MK-5172) (Grazoprevir)
• Peginterferon (Pegylated interferon)
• Ribavirin (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2016-03-02